New York State Common Retirement Fund Vaxcyte, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Vaxcyte, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 57,381 shares of PCVX stock, worth $5.25 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
57,381
Previous 57,476
0.17%
Holding current value
$5.25 Million
Previous $4.34 Million
51.08%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding PCVX
# of Institutions
354Shares Held
122MCall Options Held
775KPut Options Held
433K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.05 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$999 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$909 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$795 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$448 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.42B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...